Previous Next

News Releases    Medical/Health Care

Translations: 


Medical/Health Care Results: 789 item(s)
WICHITA, Kansas and HAIFA, Israel, Dec. 14, 2017 /PRNewswire-AsiaNet/ -- - The medical device company is transforming neurological treatments through its non-invasive focused ultrasound applications Koch Disruptive Technologies, a subsidiary of Koch Industries focused on finding and funding innovative and emerging ...
HSINCHU, Taiwan, Dec. 14, 2017 /PRNewswire-AsiaNet/ -- Industry's first 6-in-1 biosensor turns smartphones into your personal health companion MediaTek Inc. today unveiled MediaTek Sensio(TM), the first 6-in-1 smartphone biosensor module. MediaTek Sensio (https://www.mediatek.com/features/sensio-...
SOLNA, Sweden, Dec. 14, 2017 /PRNewswire-AsiaNet/ -- While Australia has faced one of the harshest influenza seasons of decades[1], Eurocine Vaccines prepares for the next phase of development, a second clinical study with its first vaccine candidate Immunose™ FLU, to fight the same. (Photo...
TOKYO and KANSAS CITY, Kan., Dec. 13, 2017 /PRNewswire-AsiaNet/ -- Kangen Pharmaceuticals ("Kangen") and KC Specialty Therapeutics ("KCST") today announced that Kangen has reached an agreement with KCST and agreed to acquire the assets of KCST. Kangen intends to retain operations in Kansas City, Kansas, USA, with...
BOTHELL, Wash., BERKELEY, Calif., SOUTH SAN FRANCISCO, Dec. 13, 2017 /PRNewswire-AsiaNet/- CMC ICOS Biologics, Inc. ("CMC Biologics"), a global leader in clinical and commercial manufacturing of therapeutic proteins, and Harpoon Therapeutics, an immuno-oncology company using its proprietary TriTAC(TM) technology platform to discover and...
DARMSTADT, Germany, Dec. 11, 2017 /PRNewswire-AsiaNet/ -- - Merck to distribute top lipid portfolio outside of United States - Improves customer access through e-commerce platform Merck [https://www.merckgroup.com/en ] , a leading science and technology company, today announced that it ha...
BAGSVAERD, Denmark, Dec. 11 /PRNewswire-AsiaNet/ -- Results published in Diabetes, Obesity and Metabolism Newly published data from real-world European clinical practice has shown that Xultophy(R) (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diab...
WALTHAM, Mass., Dec. 11, 2017 /PRNewswire-AsiaNet/ -- - At 24 months Ropeginterferon alfa-2b: Demonstrated superiority over best available treatment Achieved high rates and durable clinical and hematological response Confirmed favorable safety and tolerability profile beyond 24 months Further dem...
SINGAPORE, Dec. 11, 2017 /PRNewswire-AsiaNet/ -- Fullerton Healthcare Corporation Limited (Fullerton Health) today announced that it has entered into agreements to acquire a 60% stake in the Intellicare Group, one of the leading managed care providers in the Philippines. The Philippines is an im...
WALTHAM, Massachusetts, Dec. 10, 2017 /PRNewswire-AsiaNet/ -- -- At 24 months Ropeginterferon alfa-2b: Demonstrated superiority over best available treatment Achieved high rates and durable clinical and hematological response Confirmed favorable safety and tolerability profile beyond 24 mo...

Previous Page Page 1 of 79 Next Page 1  2  3  4  5  6  7  8  9  10  ... Go to page Go